Mortality of Parkinson's disease by Hoehn-Yahr stage from community-based and clinic series [keelung Community-based Integrated Screening (KCIS) no. 17)]

Journal of Evaluation in Clinical Practice

Volumn 15, Issue 4, 2009, Pages 587-591

  Liou, Horng Huei ^a,b   Wu, Chia Yun ^c   Chiu, Yueh Hsia ^c   Yen, Amy Ming Fang ^c   Chen, Rong Chi ^d   Chen, Ta Fu ^a   Chen, Chih Chuan ^a   Hwang, Yuarn Chung ^e   Wen, Ying Rong ^f   Chen, Tony Hsiu Hsi ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d EN CHU KONG HOSPITAL   (Taiwan)

^e KEELUNG HOSPITAL   (Taiwan)

^f NONE   (Taiwan)

Author keywords

Early detection; Hoehn Yahr stage; Parkinson's disease; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SURVIVAL RATE;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; EARLY DIAGNOSIS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TAIWAN;

EID: 68349092845     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2008.01041.x     Document Type: Article

References (13)

1. The Parkinson Study Group (1989) DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Archives of Neurology, 46, 1052 1060.
2. The Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The New England Journal of Medicine, 328, 176 183.
3. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Annals of Neurology, 39, 29 36.
4. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects requiring levodopa. Annals of Neurology, 39, 37 45.
5. The Parkinson Study Group (1998) Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Annals of Neurology, 43, 318 325.
6. Olanow, C. W., Hauser, R. A., Gauger, L., Malapira, T., Koller, W., Hubble, J., Bushenbark, K., Lilienfeld, D., Esterlitz, J. (1995) The effect of deprenyl and levodopa on the progression of Parkinson's disease. Annals of Neurology, 38, 771 777.
7. Lee, C. S., Schulzer, M., Mak, E. K., Snow, B. J., Tsui, J. K., Clane, S., Hammerstad, J., Clane, D. B. (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain, 117, 501 507.
8. Hoehn, M. M. Yahr, M. D. (1967) Parkinsonism: onset, progression and mortality. Neurology, 17, 427 442.
9. Chen, R. C., Chang, S. F., Su, C. L., Chen, T. H. H., Yen, M. F., Wu, H. M., Chen, Z. Y., Liou, H. H. (2001) Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology, 57, 1679 1686.
10. Chen, T. H. H., Chiu, Y. H., Luh, D. L., et al. (2004) Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer, 100, 1734 1743.
11. Herlofson, K., Lie, S. A., Arsland, D. Larsen, J. P. (2004) Mortality and Parkinson disease: a community based study. Neurology, 62, 937 942.
12. Fall, P. A., Saleh, A., Fredrickson, M., Olsson, J. E. Granerus, A. K. (2003) Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Movement Disorders, 18, 1312 1316.
13. Marras, C., McDermott, M. P., Rochon, P. A., Tanner, C. M., Naglie, G., Rudolph, A., Lang, A. E. 2005) Survival in Parkinson's disease: thirteen-year follow-up of the DATATOP cohort. Neurology, 64, 87 93.